NCT00139269View on ClinicalTrials.gov

Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

February 28, 1998

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Advanced Squamous Cell CarcinomaSquamous Cell Carcinoma of Head and NeckSSCHN
Interventions
DRUG

Docetaxel

DRUG

Cisplatin

DRUG

5-Fluorouracil

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Sanofi

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER